Meinian health semi annual report: the net loss in the first half of the year was 428 million yuan, and the loss narrowed

Jiuan medical: the capacity expansion of kit products will not become a loss project

Analysis of midday limit on December 1

Kexin Technology: the planned capacity of lithium iron phosphate square aluminum shell cell of the subsidiary in phase I is 1 billion wh

HEMA set up a network technology company in Nantong. Its business scope includes life beauty services

Bohui paper: as of November 30, it has bought back 1.33% of its shares

Xiangyu medical: the wholly-owned subsidiary plans to invest in the project of rehabilitation medical device industrial park

Haoneng Co., Ltd.: it plans to participate in the capital and share increase project of Sichuan Aerospace Shenkun Technology Co., Ltd. with RMB 90 million

Giant network: the net profit in the third quarter was 300 million yuan, a year-on-year decrease of 3.37%

Hengrun shares: accumulatively received performance compensation of 109 million yuan

Aikang Guobin reports two securities analysts of Guoxin Securities to China Securities Regulatory Commission

Anji Technology: the application for issuing convertible bonds was accepted by Shanghai Stock Exchange

The first phase I clinical trial of CSF-1R antibody drug in China was completed, and the first patient was administered

Yitian Intelligence: 1526664 million shares were issued, and the restricted shares of the original shareholders were lifted on December 3

Longda meat: it is proposed to invest 426 million yuan in the deep processing of imported meat and condiment production project

Financial Associated Press, December 1 - who will formulate a global agreement on epidemic prevention.